Navigation
Did you know?
Institutional Biosafety Committee (IBC)
| Overview |
| The US
National Institutes of Health (NIH) Guidelines require that an
Institutional Biosafety Committee (IBC) be established to screen
research proposals involving recombinant DNA molecules. This is not only
mandatory for institutions seeking NIH funding but it is also critical
to the safe conduct of research of this nature and to the fulfillment of
an institutional commitment to the protection of staff, the
environment, and public health. |
The composition of IBC
|
|
- Prof Virendra Rambiritch - Chair IBC
- Dr Nisha Singh- Coordinator IBC - DNA technology
- Prof Joyce Mahlako Tsoka-Gwegweni - Chair of BREC
- Dr Ann Strode - Legal
- Prof Colleen Aldous - DNA Recombinant technology
- Dr Dalene Vosloo - DNA/Biosafety, containment/animal research
- Prof Poovendhree Reddy - External, Environment
- Dr Nalini Govender - External, Public safety
|